50 related articles for article (PubMed ID: 8317892)
1. Undifferentiated carcinoma: an immunohistochemical and ultrastructural study.
Suo Z; Qvist H; Su W; Holm R; Giercksky KE; Nesland JM
Anticancer Res; 1993; 13(3):643-9. PubMed ID: 8317892
[TBL] [Abstract][Full Text] [Related]
2. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.
Hoorens A; Lemoine NR; McLellan E; Morohoshi T; Kamisawa T; Heitz PU; Stamm B; Rüschoff J; Wiedenmann B; Klöppel G
Am J Pathol; 1993 Sep; 143(3):685-98. PubMed ID: 8362971
[TBL] [Abstract][Full Text] [Related]
4. Basaloid squamous cell carcinoma of the sinonasal tract.
Wieneke JA; Thompson LD; Wenig BM
Cancer; 1999 Feb; 85(4):841-54. PubMed ID: 10091761
[TBL] [Abstract][Full Text] [Related]
5. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
6. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases.
Nagao T; Gaffey TA; Serizawa H; Sugano I; Ishida Y; Yamazaki K; Tokashiki R; Yoshida T; Minato H; Kay PA; Lewis JE
Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri.
Holm R; Abeler VM; Skomedal H; Nesland JM
Zentralbl Pathol; 1993 Jun; 139(2):153-6. PubMed ID: 8103676
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expressions of cytokeratins, mucin core proteins, p53, and neuroendocrine cell markers in epithelial neoplasm of appendix.
Yajima N; Wada R; Yamagishi S; Mizukami H; Itabashi C; Yagihashi S
Hum Pathol; 2005 Nov; 36(11):1217-25. PubMed ID: 16260276
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
10. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis.
Nagao T; Sugano I; Ishida Y; Asoh A; Munakata S; Yamazaki K; Konno A; Iwaya K; Shimizu T; Serizawa H; Ebihara Y
Mod Pathol; 2002 Jul; 15(7):724-33. PubMed ID: 12118110
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
Lewis JE; Olsen KD; Sebo TJ
Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
[TBL] [Abstract][Full Text] [Related]
12. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas.
Santos M; Landolfi S; Olivella A; Lloveras B; Klaustermeier J; Suárez H; Alòs L; Puig-Tintoré LM; Campo E; Ordi J
Am J Surg Pathol; 2006 Nov; 30(11):1347-56. PubMed ID: 17063073
[TBL] [Abstract][Full Text] [Related]
13. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
14. The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors.
Vargas MP; Vargas HI; Kleiner DE; Merino MJ
Mod Pathol; 1997 Jan; 10(1):12-7. PubMed ID: 9021722
[TBL] [Abstract][Full Text] [Related]
15. [Expression of protein p53: the marker of low neoplastic cell differentiation in thyroid carcinoma].
Szybiński P; Nowak W; Stachura J; Nowak K; Przybylik-Mazurek E; Buziak-Bereza M
Wiad Lek; 2001; 54 Suppl 1():88-94. PubMed ID: 12182067
[TBL] [Abstract][Full Text] [Related]
16. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
17. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.
Wang X; Jones TD; Maclennan GT; Yang XJ; Lopez-Beltran A; Eble JN; Koch MO; Lin H; Baldridge LA; Tretiakova M; Cheng L
Anticancer Res; 2005; 25(3B):2001-4. PubMed ID: 16158936
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
Temmim L; Baker H; Sinowatz F
Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
[TBL] [Abstract][Full Text] [Related]
20. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]